发明授权
- 专利标题: Benzodiazepin derivatives useful as CCK-receptor antagonists
- 专利标题(中): 苯并二氮杂衍生物可用作CCK受体拮抗剂
-
申请号: US867422申请日: 1997-06-06
-
公开(公告)号: US5962451A公开(公告)日: 1999-10-05
- 发明人: Hamish Ryder , Graeme Semple , David Alan Kendrick , Michael Szelke , Masato Satoh , Mitsuaki Ohta , Keiji Miyata , Akito Nishida
- 申请人: Hamish Ryder , Graeme Semple , David Alan Kendrick , Michael Szelke , Masato Satoh , Mitsuaki Ohta , Keiji Miyata , Akito Nishida
- 申请人地址: NLX JPX Tokyo
- 专利权人: Ferring BV,Yamanouchi Pharmaceutical Co. Ltd.
- 当前专利权人: Ferring BV,Yamanouchi Pharmaceutical Co. Ltd.
- 当前专利权人地址: NLX JPX Tokyo
- 优先权: GBX9204221 19920227; GBX9212740 19920616
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; A61K31/44 ; A61K31/4427 ; A61K31/55 ; A61K31/551 ; A61K31/5513 ; A61P1/04 ; A61P25/00 ; A61P43/00 ; C07D243/24 ; C07D243/34 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07D403/06 ; C07D405/06 ; C07D243/10
摘要:
A benzodiazepine derivative of formula (I), or a pharmaceutically acceptable salt thereof, wherein (a) R.sup.1 is --CH.sub.2 CHOH(CH.sub.2).sub.a R.sup.4 or a ketone group --CH.sub.2 CO(CH.sub.2).sub.a R.sup.5 in which a is 0 or 1 and R.sup.4 and R.sup.5 are selected from alkyl and cycloalkyl groups and saturated heterocyclic groups optionally substituted at a hetero-atom; (b) R.sup.2 and R.sup.3 are independently selected from aromatic carbocyclic and heterocylic residues; and (c) W and X are selected independently from halogen and hydrogen atoms and alkyl and alkoxy groups. These compounds are gastrin and/or CCK-B receptor antagonists. ##STR1##
公开/授权文献
信息查询